Medinet CoTSE:2370 41 Market Cap is 円6,972.9 Mil as of Jul. 13, 2026. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,423 Biotechnology companies, Medinet Co ranks worse than 65.64% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medinet Co's share price for the quarter that ended in Mar. 2026 was 円29. Medinet Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 277.4 Mil. Therefore, Medinet Co's market cap for the quarter that ended in Mar. 2026 was 円8,045.1 Mil.
Medinet Co's quarterly market cap
declined
from Sep. 2025 (円9,265.5 Mil) to Dec. 2025 (円7,677.1 Mil) but then
increased
from Dec. 2025 (円7,677.1 Mil) to Mar. 2026 (円8,045.1 Mil).
Medinet Co's annual market cap
increased
from Sep. 2023 (円11,608.1 Mil) to Sep. 2024 (円12,167.7 Mil) but then
declined
from Sep. 2024 (円12,167.7 Mil) to Sep. 2025 (円9,265.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medinet Co's Enterprise Value for Today is 円3,802.8 Mil.
Medinet Co (TSE:2370) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medinet Co Market Cap Related Terms
Medinet Co Market Cap Historical Data
* Premium members only.
The historical data trend for Medinet Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Medinet Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Medinet Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medinet Co's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a Market Cap of 円6,972.9 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medinet Co and its competitors. According to the industry distribution chart, Medinet Co ranks #934 out of 1423 companies in the Biotechnology industry, placing it in the top 65.6%.
Is Medinet Co's Market Cap too high?
Medinet Co's current Market Cap is 円6,972.9 Mil. Based on the distribution chart, Medinet Co ranks #934 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #934 out of 1423 companies for Market Cap. This places Medinet Co in the lower half of its industry. The industry median Market Cap is 119.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.31, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current Market Cap is 円6,972.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current Market Cap is 円6,972.9 Mil. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Market Cap is 円6,972.9 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
Market Cap: 円6,972.9 Mil
GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score
Get the complete analysis for TSE:2370
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
